Molecular predictors for decitabine efficacy in meningiomas – a pilot study-Reference-Cited by-同舟云学术

Molecular predictors for decitabine efficacy in meningiomas – a pilot study

Published:2023-07-21 Issue:1 Volume:164 Page:97-105
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Spille Dorothee C.,Thomas Christian,Wagner Andrea,Grauer Oliver Martin,Canisius Julian,Bunk Eva Christine,Stummer Walter,Eich Hans T.,Paulus Werner,Senner Volker,Brokinkel Benjamin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04379-3.pdf

Reference30 articles.

1. Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821–1834. https://doi.org/10.1093/neuonc/noab150

2. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

3. Brastianos PK, Kim AE, Giobbie-Hurder A, Lee EQ, Wang N, Eichler AF, Chukwueke U, Forst DA, Arrillaga-Romany IC, Dietrich J, Corbin Z, Moliterno J, Baehring J, White M, Lou KW, Larson J, de Sauvage MA, Evancic K, Mora J, Nayyar N, Loeffler J, Oh K, Shih HA, Curry WT, Cahill DP, Barker FG, Gerstner ER, Santagata S (2022) Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun 13:1325. https://doi.org/10.1038/s41467-022-29052-7

4. Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers. https://clinicaltrials.gov/ct2/show/NCT03173950. Accessed 11 November 2022

5. He PF, Zhou JD, Yao DM, Ma JC, Wen XM, Zhang ZH, Lian XY, Xu ZJ, Qian J, Lin J (2017) Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: a systematic review and meta-analysis. Oncotarget 8:41498–41507. https://doi.org/10.18632/oncotarget.17241